drugset / Trial / NCT03769935
Maintenance Therapy for Small-cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This study involves patients treated with cisplatin and etoposide (induction therapy), followed by treatment with a drug called S1 (maintenance therapy). The main purpose of this study is to determine if this type of treatment will delay the growth of the tumor and if so, for how long. The primary endpoint is progression free survival and second endpoints are toxicities, overall survival.
Timeline
- Start
- 2017-01-01
- Primary completion
- 2022-01-01
- Completion
- 2022-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-1 | Small molecule | 25 mg/m2 | Oral |
| Background | Cisplatin | Other / unclassified | 75 mg/m2 | Intravenous |
| Background | Etoposide | Small molecule | 60 mg/m2 | Intravenous |
Indications
No indication recorded.